Skip to Main Content

Paper Details

Integrating Tumor Sequencing Into Clinical Practice for Patients With Mismatch Repair-Deficient Lynch Syndrome Spectrum Cancers.
Clin Transl Gastroenterol
0
2021
BRAF, BRAF V600E, EPCAM, Lynch syndrome, MLH1, MLH1 promoter, MLH1-deficient colorectal cancers, MLH1-deficient tumors, MMR, MMR genes, MMR-deficient Lynch syndrome spectrum cancers, MSH2, MSH2-deficient, MSH6-deficient, and, MSH2-deficient, MSH6-deficient, and/or PMS2-deficient tumors, MSH6, Mismatch Repair-Deficient Lynch Syndrome Spectrum Cancers, PMS2, Patients, V600E, cancer predisposition syndrome, colorectal (62%) and endometrial (31%) cancers, germline, patients, tumor

Datasets

Release 1.2